Literature DB >> 21385243

Polypharmacy and patterns in drug prescribing at a primary healthcare centre in the Riyadh region of Saudi Arabia.

Yousif A Asiri1, Mohamed N Al-Arifi.   

Abstract

OBJECTIVE: To elucidate the various patterns in drug prescribing in a non-Ministry of Health-affiliated primary healthcare centre model (Riyadh Kharj Military Hospital) in Saudi Arabia.
METHODS: A retrospective analysis of pharmacy records of the Riyadh Kharj Military Hospital was undertaken. A total of 4781 prescriptions archived over a period of 6 months (January-June 2001) were statistically analysed using Statistical Package for the Social Sciences (SPSS). Number, types, therapeutic duration and distribution of drugs were evaluated. Age distribution and documentation adequacy were also reviewed and monitored. Therapeutic classification of drugs was carried out according to the British National Formulary system. KEY
FINDINGS: Of the total prescriptions, 47.8% were for male patients and 50.1% for females. Prescriptions for the paediatric population accounted for 19.5% whereas 13.7% of drugs were prescribed to the geriatric cohort. A mean of 2.7±1.6 drugs were prescribed per patient. In multidrug prescriptions, 32.3% contained two drugs and 22.1% prescriptions had four drugs or more. Mono-drug prescriptions accounted for 21.6% of prescriptions. Paracetamol (13.9%) was the most commonly prescribed drug followed by multivitamins and cough syrups with 5.0 and 3.7%, respectively. The most common therapeutic classes of drugs prescribed were analgesics, antipyretics, antihistamines, and vitamins and minerals, making up a third of all prescriptions. Dosage form, dose and routes of administration were not present in 21.7, 8.8 and 99.6%, respectively.
CONCLUSION: Polypharmacy appears to be a problem in primary health care, which requires stricter pharmacovigilance and constant reviewing. We recommend the establishment of an efficient local prescribing policy through an effective practice-based Pharmacy and Therapeutic Committee, training in prescribing to be introduced in medical schools and the lending of support to continuous education programmes targeting prescribing skills.
© 2011 The Authors. IJPP © 2011 Royal Pharmaceutical Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21385243     DOI: 10.1111/j.2042-7174.2010.00083.x

Source DB:  PubMed          Journal:  Int J Pharm Pract        ISSN: 0961-7671


  5 in total

1.  Prevalence and associated factors of polypharmacy among adult Saudi medical outpatients at a tertiary care center.

Authors:  Salih Bin Salih; Muhammad Yousuf; Huda Durihim; Hind Almodaimegh; Hani Tamim
Journal:  J Family Community Med       Date:  2013-09

Review 2.  Historical perspective of traditional indigenous medical practices: the current renaissance and conservation of herbal resources.

Authors:  Si-Yuan Pan; Gerhard Litscher; Si-Hua Gao; Shu-Feng Zhou; Zhi-Ling Yu; Hou-Qi Chen; Shuo-Feng Zhang; Min-Ke Tang; Jian-Ning Sun; Kam-Ming Ko
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-27       Impact factor: 2.629

3.  Metformin Use Is Not Associated With B12 Deficiency or Neuropathy in Patients With Type 2 Diabetes Mellitus in Qatar.

Authors:  Tarik Elhadd; Georgios Ponirakis; Zeinab Dabbous; Mashhood Siddique; Subitha Chinnaiyan; Rayaz A Malik
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-25       Impact factor: 5.555

4.  Correlates of Psychotropic Polypharmacy in outpatient psychiatric clinics of two military tertiary hospitals in Saudi Arabia.

Authors:  Fares F Alharbi; Samar F Alharbi; Saleh Bin Salih; Khaled Al-Surimi
Journal:  J Family Community Med       Date:  2019 Sep-Dec

5.  Characteristics of Saudi patients with congestive heart failure and adherence to management guidelines in a tertiary hospital in Riyadh.

Authors:  Mohammad Alqahtani; Thari Alanazi; Salih Binsalih; Naji Aljohani; Mohammed Alshammari; Ali Ashagag; Mohammed Abdullah; Sara Buabbas; Manar Abdulbaqi
Journal:  Ann Saudi Med       Date:  2012 Nov-Dec       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.